517 related articles for article (PubMed ID: 27461174)
1. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Park MH; Kim SY; Roh EY; Lee HS
Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
[TBL] [Abstract][Full Text] [Related]
2. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
3. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
[TBL] [Abstract][Full Text] [Related]
5. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients.
Khodayary R; Nikokar I; Mobayen MR; Afrasiabi F; Araghian A; Elmi A; Moradzadeh M
BMC Res Notes; 2019 Jan; 12(1):28. PubMed ID: 30646938
[TBL] [Abstract][Full Text] [Related]
6. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
[TBL] [Abstract][Full Text] [Related]
7. Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.
Agnello M; Wong-Beringer A
PLoS One; 2012; 7(8):e42973. PubMed ID: 22905192
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
[TBL] [Abstract][Full Text] [Related]
9. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
Jarjees KK
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
[TBL] [Abstract][Full Text] [Related]
11. [Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection].
Zhao RZ; Zheng YJ; Chen Q
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):672-7. PubMed ID: 23158816
[TBL] [Abstract][Full Text] [Related]
12. The Impact of ExoS on
Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ
mBio; 2018 May; 9(3):. PubMed ID: 29717012
[No Abstract] [Full Text] [Related]
13. Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.
El-Solh AA; Hattemer A; Hauser AR; Alhajhusain A; Vora H
Crit Care Med; 2012 Apr; 40(4):1157-63. PubMed ID: 22080633
[TBL] [Abstract][Full Text] [Related]
14. Study on Virulence Genes of Type III Secretion System of Pseudomonas aeruginosa in Xinjiang Province.
Yi H; Sun Q; Wang X; Liu Y; Feng N; Zhang L; Song W; Shang X; Li X; Ma X
Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383413
[TBL] [Abstract][Full Text] [Related]
15. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis.
Zhu H; Conibear TC; Bandara R; Aliwarga Y; Stapleton F; Willcox MD
Curr Eye Res; 2006 Apr; 31(4):297-306. PubMed ID: 16603462
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of cytotoxicity effectors in nosocomial Pseudomonas Aeruginosa strains].
Kuznetsova MV; Maksimova AV; Karpunina TI; Demakov VA
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):9-14. PubMed ID: 25816507
[TBL] [Abstract][Full Text] [Related]
17. The role of type III secretion system and lens material on adhesion of Pseudomonas aeruginosa to contact lenses.
Shen EP; Tsay RY; Chia JS; Wu S; Lee JW; Hu FR
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6416-26. PubMed ID: 22918630
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Virulence Genes Associated with Type III Secretion System and Biofilm Formation in Pseudomonas aeruginosa Clinical Isolates.
Ali ASBE; Ozler B; Baddal B
Curr Microbiol; 2023 Oct; 80(12):389. PubMed ID: 37880467
[TBL] [Abstract][Full Text] [Related]
19. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.
Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP
Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496
[TBL] [Abstract][Full Text] [Related]
20. Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.
Cho HH; Kwon KC; Kim S; Koo SH
Ann Lab Med; 2014 Jul; 34(4):286-92. PubMed ID: 24982833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
